TTI Thiogenesis Therapeutics, Corp.

0.4124USD0.5900 CAD · TSXV-1.67%Mkt Cap: 28.86M USDP/E: —

Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. The company lead product candidate is TTI-0102, a prodrugs t…